The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).
Age: Birth - 18 years
Gender: All
We've found 2 total result s for "Histiocytosis LangerhansCell".
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).
Age: Birth - 18 years
Gender: All
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).
Age: Birth - 18 years
Gender: All